Kaleido Biosciences' Unattributed VC Round

Kaleido Biosciences raised a round of funding on September 18, 2017.

Kaleido Biosciences is a clinical-stage biotechnology company leading the discovery and development of novel chemistries to drive functions of the microbiome organ to treat disease and improve human h…

Articles about Kaleido Biosciences' Unattributed VC Round: